Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for
时间:2019-05-26 13:11 来源:百度新闻 作者:巧天工 点击:次
Aeglea BioTherapeutics to Present Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders
2019-04-01 20:03:44 globenewswire
(责任编辑：波少) |